Biography Health

What Biography Health does

Biography Health is a privately held precision medicine company founded in 2020 by Bill Turpin (CEO) and Dr. William Stanford (CMO), headquartered in Columbia, Missouri. The company offers clinical-grade whole genome sequencing combined with AI-powered analysis to consumers and physicians, integrating genomic data with personal health history, family history, lifestyle factors, and lab results into a single clinically reviewed report (the 'DNAbled Blueprint'). Its two product tiers — Foundation at $549 (microarray-based) and Whole Story at $1,199 (whole genome sequencing at up to 98% coverage with lifetime reanalyzability) — are sold primarily direct-to-consumer through its website, with a parallel physician-referral channel targeting primary care physicians, internists, cardiologists, oncologists, psychiatrists, and other specialists who lack in-house genomics infrastructure.

The underlying technology stack combines whole genome sequencing (up to 6 billion base pairs) with proprietary analytical modules including polygenic risk scores (10,000+ conditions), monogenic variant screening (BRCA1/2, Lynch Syndrome, Factor V Leiden, Familial Hypercholesterolemia, full ACMG secondary findings), pharmacogenomic analysis across 150+ medications (CYP2D6, CYP2C19, CYP2C9, CYP3A4), and specialized scores such as Galatea Cancer & Cardiometabolic PRS and BTG clinical-grade variant analysis. All sequencing is performed in CLIA-certified, CAP-accredited laboratories with HIPAA-compliant data handling. Sample collection uses an at-home saliva cheek swab (~5 minutes), with 4-6 week turnaround from kit shipment to portal delivery.

The business model is purely cash-pay (no insurance acceptance; HSA/FSA eligible) with one-time payments per plan and no recurring fees, positioning the Whole Story genome data as a permanent, appreciating health asset that can be reanalyzed as new science emerges. Go-to-market combines self-serve e-commerce, content-led organic marketing (blog, SEO, newsletter), and physician-network referral partnerships. The company employs 1-10 people, holds a single seed-stage investment from Redbud VC (May 2024), and has not disclosed revenue figures.

Name

Biography Health

Legal name

Biography Health, Inc

Website

https://biographyhealth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Biography Health sells clinical-grade whole genome sequencing with AI-powered, physician-reviewed reports to health-conscious US consumers ($549-$1,199 one-time) and to physicians via a referral network, integrating genomics with personal and family health history.

Ownership category

akta.pro rank

Product category

Genomic Health Testing

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAAANAA

Genomic Profiling & Sequencing-Based Precision Medicine

Healthcare & Life Sciences/Biotechnology & Biologics/Precision Medicine Solutions

SECONDARYHLAAANAL

Population Genomics & Preventive Precision Health Programs

Healthcare & Life Sciences/Biotechnology & Biologics/Precision Medicine Solutions

SECONDARYHLAAALAD

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAFAMAE

Molecular Diagnostics & Genomics Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

Keywords

• Whole genome sequencing
• Precision medicine services
• Pharmacogenomics testing
• Polygenic risk scores
• Genomic health analysis

Headquarters

HQ city

Columbia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Whole Story Genomic Health Plan: One-time payment of $1,199 for the most comprehensive genomic health analysis. Includes microarray + whole genome sequencing (up to 98% coverage), ancestry analysis, monogenic variant screening (BRCA1/2, Lynch Syndrome, Factor V Leiden, Familial Hypercholesterolemia, full ACMG secondary findings), pharmacogenomics, polygenic risk scores, carrier screening, rare disease variant detection, and lifetime report updates as new science emerges. One-time purchase with no recurring fees.
2. Foundation Genomic Health Plan: One-time payment of $549 for microarray-based genetic analysis covering well-studied genetic variants. Includes polygenic risk scores across conditions, pharmacogenomic medication blueprint, fitness & nutrition genetic insights, and personalized action plan. Does not include whole genome sequencing or lifetime reanalysis.
3. Physician Consultation Services: Optional consultations with precision medicine physicians to discuss genomic findings and develop personalized health plans, offered as part of both plans. Physicians can schedule demos to partner with the platform for their patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Biography Health sells direct-to-consumer precision medicine genomic health analysis through two one-time plans: Foundation ($549) using microarray genotyping and Whole Story ($1,199) combining microarray with clinical whole genome sequencing at up to 98% coverage. Both plans are powered by the proprietary DNAbled™ process, which integrates whole genome data with personal health history, family history, and lifestyle/environment data, applies polygenic risk scoring, pharmacogenomic analysis across 150+ medications, and monogenic variant screening, and delivers AI-generated clinically reviewed reports with optional precision medicine physician consultations.

Product overview

Biography Health is a precision health platform built around whole genome sequencing and AI-powered analysis. The company offers two main product tiers: Foundation ($549) using microarray technology, and Whole Story ($1,199) combining microarray with whole genome sequencing (up to 98% genome coverage). Both plans include the proprietary DNAbled™ process, pharmacogenomic analysis, polygenic risk scores, and integration with personal health history, family history, and lifestyle data. Customers receive a DNAbled Blueprint personalized report with the option for physician consultation. The Whole Story plan adds monogenic variant screening, rare variant detection, ancestry analysis, and future-proof reanalyzability as science advances.

Differentiator

Problem solved

Functional benefit

Brands

• DNAbled™: Proprietary precision medicine-based process that determines unique genetic makeup with pinpoint accuracy and draws inferences of likely future health states, including risk of chronic diseases and premature death.

Products and services

• Foundation Genomic Health Plan

Quantifiable outcome

• Up to 98% genome coverage vs <0.1% for microarray-based tests (23andMe)
• +5 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

One partnership is on record.

• Physician Network ProviderscoreChannel Partner/ Reseller/ DistributorBiography Health maintains a network of physician partners who refer patients to the platform. Physicians include board-certified internists, cardiologists, oncologists, psychiatrists, and other specialists. The company provides a turnkey precision medicine platform; physicians receive clinician-ready reports to act on in patient appointments. No genetics expertise required on the physician's part.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Dante Labs: Dante Labs is a Europe-based DTC whole genome sequencing provider offering comprehensive health + ancestry reports. Mirrors Biography Health's high-coverage WGS, multi-condition DTC positioning at similar price points.
• Nebula Genomics: Nebula Genomics offers direct-to-consumer whole genome sequencing with multi-modal health reports, very similar in core offering to Biography Health's Whole Story plan. Both compete on WGS coverage, AI-driven insights, and pricing in the same ~$500-$1,200 band.
• 23andMe: 23andMe is the dominant DTC genetic testing brand, offering health + ancestry reports to consumers. Biography Health explicitly positions against 23andMe's microarray-based approach, citing <0.1% DNA coverage compared to WGS.
• Veritas Genetics: Veritas pioneered low-cost whole genome sequencing to consumers (the "myGenome" product), directly overlapping Biography Health's WGS-based DTC playbook including health risk and pharmacogenomic interpretation.
• Color Health: Color offers clinical-grade genetic testing to both consumers and enterprise clients (employers, health systems), covering hereditary cancer and pharmacogenomics. Compares to Biography Health on the precision medicine clinical interpretation + enterprise motion.
• Helix: Helix is a DNA sequencing platform that partners with health systems and DTC brands to deliver genomic insights. It overlaps with Biography Health both as a sequencing infrastructure layer and as a competitor to WGS-based health products.
• Ancestry (AncestryDNA): AncestryDNA is the largest DTC DNA testing brand focused on ancestry, with expanding health content. Competes with Biography Health for the same consumer who wants DNA-based health insights and is considering upgrading beyond microarray tests.
• Sequencing.com: Sequencing.com offers whole genome sequencing and a marketplace of third-party genetic apps for health, fitness, and ancestry. Overlaps with Biography Health on WGS DTC and on app-based delivery of personalized reports.

Broad incumbents

• Tempus: Tempus is a large precision medicine platform combining genomic sequencing with clinical data and AI to support oncology and other specialties. It is a broader incumbent in the precision medicine space in which Biography Health competes, particularly on the physician/enterprise channel.
• Invitae: Invitae (now part of Labcorp) is a clinical genetic testing company serving physicians across hereditary cancer, reproductive health, and pharmacogenomics. It is a broader incumbent offering overlapping capabilities on the physician-facing precision medicine channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biography-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biography Health